The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 1
  • Young, John Paul
    Company Director born in April 1968
    Individual (5 offsprings)
    Officer
    2015-02-13 ~ now
    OF - director → CIF 0
    Mr John Paul Young
    Born in April 1968
    Individual (5 offsprings)
    Person with significant control
    2016-04-06 ~ now
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
Ceased 1
  • Richardson, Marcos
    Company Director born in July 1971
    Individual (5 offsprings)
    Officer
    2015-02-13 ~ 2017-05-01
    OF - director → CIF 0
    Mr Marcos Richardson
    Born in July 1971
    Individual (5 offsprings)
    Person with significant control
    2016-04-06 ~ 2017-08-30
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
parent relation
Company in focus

WILLMAN YOUNG LTD

Previous name
PHARMA-OPTIMISE LTD - 2017-05-04
Standard Industrial Classification
99000 - Activities Of Extraterritorial Organisations And Bodies
Brief company account
Property, Plant & Equipment
421 GBP2024-03-31
561 GBP2023-03-31
Fixed Assets
421 GBP2024-03-31
561 GBP2023-03-31
Creditors
-3,179 GBP2024-03-31
-3,089 GBP2023-03-31
Net Current Assets/Liabilities
-3,179 GBP2024-03-31
-3,089 GBP2023-03-31
Total Assets Less Current Liabilities
-2,758 GBP2024-03-31
-2,528 GBP2023-03-31
Net Assets/Liabilities
-2,758 GBP2024-03-31
-2,528 GBP2023-03-31
Equity
Called up share capital
100 GBP2024-03-31
100 GBP2023-03-31
Retained earnings (accumulated losses)
-2,858 GBP2024-03-31
-2,628 GBP2023-03-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
1,330 GBP2024-03-31
1,330 GBP2023-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
909 GBP2024-03-31
769 GBP2023-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
140 GBP2023-04-01 ~ 2024-03-31
Property, Plant & Equipment
Plant and equipment
421 GBP2024-03-31
561 GBP2023-03-31
Bank Borrowings/Overdrafts
Current
6 GBP2024-03-31
6 GBP2023-03-31
Accrued Liabilities/Deferred Income
Current
1,200 GBP2024-03-31
1,800 GBP2023-03-31
Amounts owed to directors
Current
1,973 GBP2024-03-31
1,283 GBP2023-03-31
Creditors
Current
3,179 GBP2024-03-31
3,089 GBP2023-03-31

  • WILLMAN YOUNG LTD
    Info
    PHARMA-OPTIMISE LTD - 2017-05-04
    Registered number 09438663
    The Granary, Hadlow Down Road, Crowborough TN6 3SA
    Private Limited Company incorporated on 2015-02-13 (10 years 4 months). The company status is Active.
    The last date of confirmation statement was made at 2025-02-02
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.